On November, 22, 2025, the Updated Publication Summary and the Proposed Risk Management Approach were published for a 60-day public comment period. These substances are proposed to meet the […]
On November 22, 2025 the Updated Information Sheet and Final Screening Assessment were published for the Selected C3-C5 Alcohols Group. The conclusion for all six alcohols in this grouping […]
On November 22, 2025, the Final Assessment and the Proposed Risk Management Approach for the Decenes Group were published with a 60-day public comment period. These substances are proposed […]
Health Canada, together with other federal partners, conduct ongoing human biomonitoring to understand Canadians’ exposure to environmental chemicals. A key component is the Canadian Health Measures Survey (CHMS) a […]
The Natural Health Product Ingredient Database (NHPID) and monograph load will not occur on November 28, 2025, as initially planned. Due to the upcoming early December load associated […]
The Scientific Committee on Consumer Safety (SCCS) has concluded that the use of Butylated Hydroxyanisole (BHA) in leave-on and rinse-off cosmetic products is considered safe at concentrations up to […]
The Scientific Committee on Consumer Safety (SCCS) has evaluated the safety of Cannabidiol (CBD) and its contaminant Delta-9-tetrahydrocannabinol (THC) in cosmetic products, excluding those leading to inhalation exposure. The […]
The SCCS’s has concluded that there are significant safety concerns regarding the currently permitted use of Thiomersal and Phenylmercuric salts as preservatives in cosmetic eye products. The use of […]
If your business have personal care and/or cosmetic devices this consultation maybe of interest to you. Health Canada has published a 60-day public consultation ending on January 22, 2026 […]
Health Canada’s Annual Cost Recovery Stakeholder Meeting for drugs and medical devices is being held on December 5th, and Cosmetics Alliance will be attending the meeting. The Annual Cost […]
